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Abstract 
Aim: Brain perfusion imaging by means of 
99mTc-labeled hexamethyl propylene amine oxime (HMPAO) is a well-
established  Nuclear  Medicine  diagnostic  procedure.  The  administered  dose  range  recommended  by  the  supplying 
company  and  reported  in  bibliography  is  rather  wide  (approximately  9.5-27  mCi).  This  fact  necessitates  further 
quantitative analysis of the technique, so as to minimise patient absorbed dose without compromising the examination 
diagnostic value. In this study, a quantitative evaluation of the radiopharmaceutical performance for different values of 
administered dose (10, 15, 20 mCi) was carried out. Subsequently, a generic image quality index was correlated with the 
administered dose, to produce an overall performance indicator. Through this cost-to-benefit type analysis, the necessity 
of administration of higher radioactive dose levels in order to perform the specific diagnostic procedure was examined.  
Materials & methods:  The study was based on a sample of 78 patients (56 administered with 10 mCi, 10 with 15 mCi 
and 12 with 20 mCi). Some patients were classified as normal, while others presented various forms of pathology. 
Evaluation of image quality was based on contrast, noise and contrast-to-noise ratio indicators, denoted CI, NI and CNR 
respectively. Calculation of all indicators was based on wavelet transform. An overall performance indicator (denoted 
PI), produced by the ratio of CNR by administered dose, was also calculated.  
Results: Calculation of skewness parameter revealed the normality of CI, NI and non-normality of CNR, PI populations. 
Application  of appropriate  statistical  tests  (analysis  of  variance  for  normal  and  Kruskal-Wallis  test  for  non-normal 
populations) showed that there is a statistically significant difference in CI (p<0.01), NI (p<0.001) and CNR (p<0.05), 
but not for PI (p>0.05) values. Application of Tukey test for normal populations CI, NI led to the conclusion that CI(10 
mCi) = CI(20 mCi)<CI(15(mCi) and NI(10 mCi)>NI(20 mCi), while NI(15 mCi) can not be characterised. Finally, 
application of non-parametric multiple comparisons showed that CNR(20 mCi)>CNR(10 mCi), while CNR(15 mCi) can 
not be characterised. 
Conclusion: Brain perfusion imaging by means of 
99mTc- HMPAO utilising an administered dose of 20 mCi results in 
improved image quality, on the basis of the estimated indicators and for the range of radioactive dose levels examined. 
Additionally, this image quality improvement is sufficient to justify the increased radiation burden for the patient.  
Keywords:  brain perfusion imaging, 
99mTc-HMPAO, wavelet transform, quantitative evaluation..
___________________________________________________________________________________________ 
1. Introduction 
Modern clinical practice is based on a plethora of diagnostic 
tools for the accurate diagnostic assessment of various forms 
of  pathology.  Nuclear  medicine  diagnostic  examinations, 
also called scintigraphic examinations, are widely employed, 
due to their high diagnostic efficacy (Wolbarst  [1]). In order 
to  perform  these  examinations,  a  radioactive  substance  is 
locally  concentrated  in  target  organs  under  consideration. 
These  radioactive  substances  are  called 
radiopharmaceuticals and are administered either orally or 
intravenously (Uslu et al [2], Ha Phan et al [3]). After the 
elapse of a time interval, which is necessary to ensure the 
localisation of the radiopharmaceutical to the target region 
and its value is specific for each scintigraphic examination, 
the imaging procedure begins, by utilising gamma camera 
systems.  Planar  as  well  as  tomographic  projections  are 
acquired,  resulting  in  highlighting  of  physiology  and 
possible pathology of the target organs.  
2. Aim 
Brain  perfusion  imaging  by  means  of 
99mTc-labeled
hexamethyl  propylene  amine  oxime  (HMPAO)  is  a  well-
established Nuclear Medicine diagnostic procedure (Cavallin 
et al [4]). It is a method of great clinical importance for the 
diagnosis of Alzheimer’s disease, through the differentiation 
of small changes in the regional cerebral blood flow (Ansar 
et al [5], Koulibaly et al [6]). The administered dose range 
recommended  by  the  supplying  company  and  reported  in 
bibliography  is  rather  wide  (approximately  9.5-27  mCi). 
This  fact  necessitates  further  quantitative  analysis  of  the 
technique, so as to minimise patient absorbed dose without 
compromising  the  examination  diagnostic  value.  In  this 
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study, a quantitative evaluation of the radiopharmaceutical 
performance for different values of administered dose (10, 
15,  20  mCi)  was  carried  out,  via  application  of  image 
analysis techniques (Stefanoyiannis et al [7], Stefanoyiannis 
et al [8]). Typical examples of brain perfusion imaging by 
means of 
99mTc-HMPAO and administered dose levels of 10, 
15  and  20  mCi  are  presented  in  figures  1-3  respectively. 
Subsequently, a generic image quality index was correlated 
with  the  administered  dose,  to  produce  an  overall 
performance  indicator.  Through  this  cost-to-benefit  type 
analysis,  the  necessity  of  administration  of  higher 
radioactive  dose  levels  in  order  to  perform  the  specific 
diagnostic procedure was examined.  
Fig 1. Brain perfusion imaging. Radiopharmaceutical: 
99mTc-HMPAO, 
administered dose level: 10 mCi.
Fig 2. Brain perfusion imaging. Radiopharmaceutical: 
99mTc-HMPAO, 
administered dose level: 15 mCi.
Fig 3. Brain perfusion imaging. Radiopharmaceutical: 
99mTc-HMPAO, 
administered dose level:  20 mCi. 
3. Materials & methods 
A sample of 78 patients (classified as normal or presenting 
various forms of pathology) was utilised. The administered 
dose was 10 mCi for 56 patients, 15 mCi for 10 patients and 
20 mCi for 12 patients.   Evaluation of image quality was 
based  on  contrast,  noise  and  contrast-to-noise  ratio 
indicators,  denoted  CI,  NI  and  CNR  respectively. 
Calculation of all indicators was based on wavelet transform 
(Laine et al [9], Mallat and Hwang [10], Zong and Laine 
[11]).  An  overall  performance  indicator  (denoted  PI), 
produced by the ratio of CNR by administered dose, was 
also calculated. 
  In  order  to  derive  the  contrast  indicator,  the  non-
subsampled  biorthogonal  discrete  wavelet  transform  (NB 
DWT)  has  been  used.  The  magnitudes  of  wavelet 
coefficients in the 2nd scale, corresponding to a certain ROI 
sampling the brain region, are used for contrast estimation. 
Specifically,  the  wavelet  coefficient  magnitudes  are 
averaged to determine the contrast indicator (Costaridou et 
al [12]). 
  The NB DWT has also been exploited for noise indicator 
estimation. Particularly, the 1st scale of the NB DWT has 
been utilised, as it is the scale mostly contaminated by noise. 
Noise  indicator  in  brain  region  is  estimated  as  the  mean 
power of the magnitude wavelet coefficients, ranging from 
zero up to a threshold, called reference noise power. The 
reference noise power is estimated as the mean power of the 
1st scale magnitude wavelet coefficients in the signal-free 
background of the image (Stefanoyiannis et al [13]). 
4. Results 
Figure 4 shows the results of the estimation of image quality 
indicators  CI,  NI  and  CNR  and  the  overall  performance 
indicator PI for the subsamples of 10, 15 and 20 mCi.. 
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Fig 4. Results of indicators’ estimation.
  The  results  of  quantitative  evaluation  are  presented  in 
table 1, where the % differences of estimated indicators for 
15  mCi  and  20  mCi  subsamples  versus  the  control 
subsample of 10 mCi are reported.  5. Conclusions 
Table 1.
Results of quantitative evaluation 
CI NI CNR PI
% diff. (15 mCi vs. 10 
mCi)  14.58  -25.13  24.41  -17.06 
% diff. (20 mCi vs. 10 
mCi)  -1.18  -52.09  78.01  -11.00 
Brain perfusion imaging by means of 
99mTc-HMPAO  is  a 
well-established Nuclear Medicine diagnostic procedure for 
the  detection  of  Alzheimer’s  disease.  Recent  studies 
performing  patient-by-patient  comparison  between  this 
technique  and  DSC-MRI  (a  technique  based  on  nuclear 
magnetic resonance) proved the superiority of the former in 
the diagnosis of Alzheimer’s disease, as well as the other 
forms of dementia (Cavallin et al [4], Kubota et al [14]). 
Therefore, optimisation of the administered dose to carry out 
the specific examination is rather crucial. According to the 
results  of  the  present  study,  brain  perfusion  imaging  by 
means of 
99mTc- HMPAO utilising an administered dose of 
20 mCi results in improved image quality, on the basis of the 
estimated  indicators  (for  the  range  of  administered  dose 
values  examined).  Additionally,  this  image  quality 
improvement  is  sufficient  to  justify  the  increased  patient 
absorbed dose. As an open issue, the future study of image 
quality for higher values of administered dose is mentioned, 
always  in  the  framework  of  internationally  acceptable 
clinical practice.  
  In Table 2, the results of further statistical analysis are 
presented.  
Table 2.
Statistical analysis 
PARAMETER  POPULATION  STATISTICAL 
TEST
RESULT
CI normal  ANOVA      SS 
(p<0.01) 
NI normal  ANOVA      SS 
(p<0.001) 
CNR non-Gaussian Kruskal-Wallis      SS 
(p<0.05) 
PI non-Gaussian Kruskal-Wallis      SNS 
(p>0.05) 
Abbreviations:  CI:  contrast  indicator,  NI:  noise  indicator,  CNR : 
contrast-to-noise ratio, PI : performance indicator, ANOVA : analysis of 
variance, SS : statistically significant, SNS : statistically non-significant. 
______________________________ 
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